The CMAJ guidance A guidance article published in the Canadian Medical Association Journal (CMAJ) on glucagon-like peptide-1 receptor agonists during pregnancy and lactation concluded that while the safety data is limited, the pharmacological properties of GLP-1 agonists (large molecular weight, poor oral bioavailability) suggest low theoretical risk during breastfeeding
Researchers sometimes pair it with BPC-157, another recovery peptide, to hypothesize possible synergistic repair effects in lab models
Over time, this can reduce thyroid hormone production, leading to hypothyroidism and symptoms such as weight gain, fatigue, sensitivity to cold and a slower metabolism
To address this, we attempted to identify potential sources of heterogeneity by conducting meta-regression analyses on variables such as the average drug dosage, study duration, average age, and proportion of male participants
Considering these findings observed across a large, real-world cohort, the researchers concluded that avoidance of semaglutide based solely on concerns regarding the risk of NAION may not be warranted, as its potential benefits for blood glucose control and cardiovascular health likely outweigh its potential risks.
They will use a syringe to inject the B12 directly into your muscle